Palbociclib (PD-0332991)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Palbociclib (PD-0332991), covering 2013-09-09 to 2013-09-09. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasia [Phase 1]